nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—TOP2A—adrenal gland cancer	0.338	1	CbGaD
Epirubicin—thyroid cancer—adrenal gland cancer	0.184	0.309	CtDrD
Epirubicin—liver cancer—adrenal gland cancer	0.177	0.298	CtDrD
Epirubicin—pancreatic cancer—adrenal gland cancer	0.12	0.203	CtDrD
Epirubicin—testicular cancer—adrenal gland cancer	0.113	0.19	CtDrD
Epirubicin—CHD1—adrenal cortex—adrenal gland cancer	0.00186	0.0721	CbGeAlD
Epirubicin—CHD1—gonad—adrenal gland cancer	0.00154	0.0597	CbGeAlD
Epirubicin—CHD1—cardiac atrium—adrenal gland cancer	0.00154	0.0596	CbGeAlD
Epirubicin—CHD1—pituitary gland—adrenal gland cancer	0.00151	0.0583	CbGeAlD
Epirubicin—Daunorubicin—NR5A1—adrenal gland cancer	0.00149	0.342	CrCbGaD
Epirubicin—CHD1—adrenal gland—adrenal gland cancer	0.00135	0.0521	CbGeAlD
Epirubicin—AURKA—Gastric Cancer Network 1—TOP2A—adrenal gland cancer	0.00131	0.0344	CbGpPWpGaD
Epirubicin—DHCR7—adrenal cortex—adrenal gland cancer	0.00126	0.0486	CbGeAlD
Epirubicin—Valrubicin—TOP2A—adrenal gland cancer	0.00126	0.287	CrCbGaD
Epirubicin—AURKA—gonad—adrenal gland cancer	0.00124	0.0481	CbGeAlD
Epirubicin—AURKA—pituitary gland—adrenal gland cancer	0.00121	0.047	CbGeAlD
Epirubicin—UGT2B7—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0012	0.0316	CbGpPWpGaD
Epirubicin—YWHAG—adrenal cortex—adrenal gland cancer	0.00115	0.0446	CbGeAlD
Epirubicin—AURKA—Aurora A signaling—PRKACA—adrenal gland cancer	0.00109	0.0287	CbGpPWpGaD
Epirubicin—AURKA—adrenal gland—adrenal gland cancer	0.00108	0.042	CbGeAlD
Epirubicin—DHCR7—gonad—adrenal gland cancer	0.00104	0.0403	CbGeAlD
Epirubicin—DHCR7—cardiac atrium—adrenal gland cancer	0.00104	0.0402	CbGeAlD
Epirubicin—DHCR7—pituitary gland—adrenal gland cancer	0.00102	0.0393	CbGeAlD
Epirubicin—YWHAG—gonad—adrenal gland cancer	0.000955	0.037	CbGeAlD
Epirubicin—YWHAG—cardiac atrium—adrenal gland cancer	0.000954	0.0369	CbGeAlD
Epirubicin—YWHAG—pituitary gland—adrenal gland cancer	0.000932	0.036	CbGeAlD
Epirubicin—YWHAG—IL3-mediated signaling events—PRKACA—adrenal gland cancer	0.000926	0.0243	CbGpPWpGaD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—DAXX—adrenal gland cancer	0.000923	0.0242	CbGpPWpGaD
Epirubicin—DHCR7—adrenal gland—adrenal gland cancer	0.000907	0.0351	CbGeAlD
Epirubicin—YWHAG—Activation of BAD and translocation to mitochondria—BAD—adrenal gland cancer	0.000877	0.023	CbGpPWpGaD
Epirubicin—PLA2G4A—adrenal cortex—adrenal gland cancer	0.00086	0.0333	CbGeAlD
Epirubicin—YWHAG—adrenal gland—adrenal gland cancer	0.000832	0.0322	CbGeAlD
Epirubicin—YWHAG—Class I PI3K signaling events mediated by Akt—PRKACA—adrenal gland cancer	0.000753	0.0198	CbGpPWpGaD
Epirubicin—Idarubicin—TOP2A—adrenal gland cancer	0.000721	0.165	CrCbGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—SH3KBP1—adrenal gland cancer	0.000707	0.0186	CbGpPWpGaD
Epirubicin—PLA2G4A—pituitary gland—adrenal gland cancer	0.000695	0.0269	CbGeAlD
Epirubicin—AURKA—Integrin-linked kinase signaling—CDC42—adrenal gland cancer	0.000689	0.0181	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.000646	0.0169	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—PRKACA—adrenal gland cancer	0.000638	0.0168	CbGpPWpGaD
Epirubicin—PLA2G4A—adrenal gland—adrenal gland cancer	0.000621	0.024	CbGeAlD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.000616	0.0162	CbGpPWpGaD
Epirubicin—TOP2A—adrenal gland—adrenal gland cancer	0.00059	0.0228	CbGeAlD
Epirubicin—YWHAG—Activation of BH3-only proteins—BAD—adrenal gland cancer	0.000583	0.0153	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—adrenal gland cancer	0.000532	0.014	CbGpPWpGaD
Epirubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—PRKACA—adrenal gland cancer	0.000532	0.014	CbGpPWpGaD
Epirubicin—AURKA—Regulation of PLK1 Activity at G2/M Transition—PRKACA—adrenal gland cancer	0.000518	0.0136	CbGpPWpGaD
Epirubicin—PLA2G4A—Ca-dependent events—PRKACA—adrenal gland cancer	0.000516	0.0135	CbGpPWpGaD
Epirubicin—ABCC1—adrenal cortex—adrenal gland cancer	0.000492	0.019	CbGeAlD
Epirubicin—YWHAG—Loss of Nlp from mitotic centrosomes—PRKACA—adrenal gland cancer	0.000483	0.0127	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.000467	0.0123	CbGpPWpGaD
Epirubicin—YWHAG—Class I PI3K signaling events mediated by Akt—BAD—adrenal gland cancer	0.000446	0.0117	CbGpPWpGaD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—BAD—adrenal gland cancer	0.000436	0.0114	CbGpPWpGaD
Epirubicin—YWHAG—Centrosome maturation—PRKACA—adrenal gland cancer	0.000427	0.0112	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MEN1—adrenal gland cancer	0.000419	0.011	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—BAD—adrenal gland cancer	0.000417	0.0109	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—SPRY2—adrenal gland cancer	0.000417	0.0109	CbGpPWpGaD
Epirubicin—ABCC1—cardiac atrium—adrenal gland cancer	0.000407	0.0157	CbGeAlD
Epirubicin—ABCC1—pituitary gland—adrenal gland cancer	0.000398	0.0154	CbGeAlD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—CDC42—adrenal gland cancer	0.000396	0.0104	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of PLK1 Activity at G2/M Transition—PRKACA—adrenal gland cancer	0.000392	0.0103	CbGpPWpGaD
Epirubicin—AURKA—G2/M Transition—PRKACA—adrenal gland cancer	0.000389	0.0102	CbGpPWpGaD
Epirubicin—Daunorubicin—TOP2A—adrenal gland cancer	0.000387	0.0885	CrCbGaD
Epirubicin—AURKA—Mitotic G2-G2/M phases—PRKACA—adrenal gland cancer	0.000383	0.0101	CbGpPWpGaD
Epirubicin—PLA2G4A—PLC beta mediated events—PRKACA—adrenal gland cancer	0.00038	0.00996	CbGpPWpGaD
Epirubicin—PLA2G4A—G-protein mediated events—PRKACA—adrenal gland cancer	0.000373	0.00979	CbGpPWpGaD
Epirubicin—ABCC1—adrenal gland—adrenal gland cancer	0.000355	0.0137	CbGeAlD
Epirubicin—PLA2G4A—PDGF Pathway—CDC42—adrenal gland cancer	0.000355	0.00931	CbGpPWpGaD
Epirubicin—AURKA—Integrin-linked kinase signaling—CTNNB1—adrenal gland cancer	0.000316	0.0083	CbGpPWpGaD
Epirubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—BAD—adrenal gland cancer	0.000315	0.00826	CbGpPWpGaD
Epirubicin—Doxorubicin—TOP2A—adrenal gland cancer	0.000314	0.0718	CrCbGaD
Epirubicin—YWHAG—G2/M Transition—PRKACA—adrenal gland cancer	0.000295	0.00773	CbGpPWpGaD
Epirubicin—YWHAG—Mitotic G2-G2/M phases—PRKACA—adrenal gland cancer	0.000291	0.00763	CbGpPWpGaD
Epirubicin—AURKA—Aurora A signaling—TP53—adrenal gland cancer	0.000283	0.00744	CbGpPWpGaD
Epirubicin—ABCC1—ABC-family proteins mediated transport—ABCB1—adrenal gland cancer	0.000283	0.00743	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000268	0.00703	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—CDC42—adrenal gland cancer	0.000265	0.00696	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—adrenal gland cancer	0.000264	0.00694	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.000262	0.00686	CbGpPWpGaD
Epirubicin—ABCC1—S1P1 pathway—PTGS2—adrenal gland cancer	0.000259	0.00678	CbGpPWpGaD
Epirubicin—YWHAG—Activation of BH3-only proteins—TP53—adrenal gland cancer	0.000255	0.0067	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000249	0.00653	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—CDC42—adrenal gland cancer	0.000247	0.00649	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—BRAF—adrenal gland cancer	0.000244	0.00641	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—CDC42—adrenal gland cancer	0.000242	0.00634	CbGpPWpGaD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.000236	0.0062	CbGpPWpGaD
Epirubicin—PLA2G4A—Opioid Signalling—PRKACA—adrenal gland cancer	0.000233	0.00612	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—CDC42—adrenal gland cancer	0.000233	0.00611	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000232	0.00609	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—PRKACA—adrenal gland cancer	0.000229	0.00601	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.000228	0.00597	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—CTNNB1—adrenal gland cancer	0.000226	0.00593	CbGpPWpGaD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.000225	0.00589	CbGpPWpGaD
Epirubicin—YWHAG—FoxO family signaling—CTNNB1—adrenal gland cancer	0.000224	0.00588	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000216	0.00566	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—adrenal gland cancer	0.000198	0.00521	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000198	0.00521	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—GNAS—adrenal gland cancer	0.000195	0.00511	CbGpPWpGaD
Epirubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—adrenal gland cancer	0.000194	0.00508	CbGpPWpGaD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.000191	0.00502	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—EGFR—adrenal gland cancer	0.00019	0.00498	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—GNAS—adrenal gland cancer	0.000185	0.00487	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—BAD—adrenal gland cancer	0.000185	0.00485	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—SDHB—adrenal gland cancer	0.000184	0.00483	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—adrenal gland cancer	0.000183	0.00479	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.000183	0.00479	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—adrenal gland cancer	0.000181	0.00475	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—EGFR—adrenal gland cancer	0.000179	0.0047	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—RB1—adrenal gland cancer	0.000169	0.00444	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—BRAF—adrenal gland cancer	0.000168	0.00442	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.000166	0.00436	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—adrenal gland cancer	0.000165	0.00434	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.000163	0.00429	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—BRAF—adrenal gland cancer	0.000157	0.00412	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—adrenal gland cancer	0.000151	0.00397	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—adrenal gland cancer	0.00015	0.00394	CbGpPWpGaD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000149	0.00392	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—adrenal gland cancer	0.000149	0.00391	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—BRAF—adrenal gland cancer	0.000146	0.00384	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000145	0.0038	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.00014	0.00369	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—BAD—adrenal gland cancer	0.000135	0.00356	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.000135	0.00353	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000133	0.0035	CbGpPWpGaD
Epirubicin—PLA2G4A—Opioid Signalling—POMC—adrenal gland cancer	0.000127	0.00334	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TOP2A—adrenal gland cancer	0.000126	0.0033	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.000124	0.00325	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.000124	0.00325	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.00012	0.00315	CbGpPWpGaD
Epirubicin—ABCC1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000119	0.00313	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—RRM1—adrenal gland cancer	0.000118	0.00311	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—SDHD—adrenal gland cancer	0.000118	0.00311	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.000118	0.0031	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—PRKACA—adrenal gland cancer	0.000111	0.0029	CbGpPWpGaD
Epirubicin—Daunorubicin—ABCB1—adrenal gland cancer	0.00011	0.0252	CrCbGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000108	0.00283	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.000106	0.00279	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—EGFR—adrenal gland cancer	9.64e-05	0.00253	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TOP2A—adrenal gland cancer	9.52e-05	0.0025	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	9.51e-05	0.0025	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	9.47e-05	0.00248	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	9.37e-05	0.00246	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	9.33e-05	0.00245	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	8.99e-05	0.00236	CbGpPWpGaD
Epirubicin—Doxorubicin—ABCB1—adrenal gland cancer	8.93e-05	0.0204	CrCbGaD
Epirubicin—YWHAG—Apoptosis—CTNNB1—adrenal gland cancer	8.91e-05	0.00234	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—BRAF—adrenal gland cancer	8.87e-05	0.00233	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	8.87e-05	0.00233	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	8.85e-05	0.00232	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—MED12—adrenal gland cancer	8.83e-05	0.00232	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	8.53e-05	0.00224	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—EGFR—adrenal gland cancer	8.47e-05	0.00222	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—PRKACA—adrenal gland cancer	8.38e-05	0.0022	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	8.32e-05	0.00218	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—adrenal gland cancer	8.29e-05	0.00217	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GNRHR—adrenal gland cancer	8.06e-05	0.00211	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	8.02e-05	0.0021	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	7.99e-05	0.0021	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	7.9e-05	0.00207	CbGpPWpGaD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—adrenal gland cancer	7.65e-05	0.00201	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TERT—adrenal gland cancer	7.53e-05	0.00197	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—POMC—adrenal gland cancer	7.1e-05	0.00186	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	6.94e-05	0.00182	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	6.72e-05	0.00176	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	6.58e-05	0.00173	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	6.56e-05	0.00172	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—RB1—adrenal gland cancer	6.55e-05	0.00172	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PRKACA—adrenal gland cancer	6.45e-05	0.00169	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SPARC—adrenal gland cancer	6.38e-05	0.00167	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SDHB—adrenal gland cancer	6.35e-05	0.00167	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.3e-05	0.00165	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SDHB—adrenal gland cancer	6.22e-05	0.00163	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TP53—adrenal gland cancer	5.93e-05	0.00156	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	5.89e-05	0.00155	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—PRKACA—adrenal gland cancer	5.86e-05	0.00154	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—RB1—adrenal gland cancer	5.86e-05	0.00154	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	5.76e-05	0.00151	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TERT—adrenal gland cancer	5.7e-05	0.0015	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PRKACA—adrenal gland cancer	5.38e-05	0.00141	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.37e-05	0.00141	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	5.27e-05	0.00138	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GNAS—adrenal gland cancer	5.22e-05	0.00137	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDKN2A—adrenal gland cancer	5.15e-05	0.00135	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ABCB1—adrenal gland cancer	5.13e-05	0.00135	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	5.11e-05	0.00134	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SH3KBP1—adrenal gland cancer	5.05e-05	0.00133	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SDHB—adrenal gland cancer	4.97e-05	0.00131	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—RB1—adrenal gland cancer	4.96e-05	0.0013	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.9e-05	0.00129	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GNRH1—adrenal gland cancer	4.83e-05	0.00127	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNRHR—adrenal gland cancer	4.76e-05	0.00125	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ZNRF3—adrenal gland cancer	4.75e-05	0.00125	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	4.57e-05	0.0012	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CDC42—adrenal gland cancer	4.56e-05	0.0012	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—RB1—adrenal gland cancer	4.44e-05	0.00116	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SH3KBP1—adrenal gland cancer	4.43e-05	0.00116	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IGF2—adrenal gland cancer	4.4e-05	0.00115	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	4.36e-05	0.00115	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—GNAS—adrenal gland cancer	4.36e-05	0.00114	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TSHR—adrenal gland cancer	4.3e-05	0.00113	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.18e-05	0.0011	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ZNRF3—adrenal gland cancer	4.16e-05	0.00109	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—RRM1—adrenal gland cancer	4.09e-05	0.00107	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SDHD—adrenal gland cancer	4.09e-05	0.00107	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—RRM1—adrenal gland cancer	4.01e-05	0.00105	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SDHD—adrenal gland cancer	4.01e-05	0.00105	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TERT—adrenal gland cancer	3.99e-05	0.00105	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.91e-05	0.00103	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—adrenal gland cancer	3.9e-05	0.00102	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.72e-05	0.000977	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.62e-05	0.00095	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—POMC—adrenal gland cancer	3.52e-05	0.000923	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.51e-05	0.000921	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—RB1—adrenal gland cancer	3.47e-05	0.000911	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—adrenal gland cancer	3.37e-05	0.000884	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SDHD—adrenal gland cancer	3.2e-05	0.000841	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—RRM1—adrenal gland cancer	3.2e-05	0.000841	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—RB1—adrenal gland cancer	3.1e-05	0.000815	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKACA—adrenal gland cancer	3.09e-05	0.00081	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	3.05e-05	0.000801	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MED12—adrenal gland cancer	3.05e-05	0.0008	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.04e-05	0.000798	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.02e-05	0.000792	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MED12—adrenal gland cancer	2.99e-05	0.000785	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SPRY2—adrenal gland cancer	2.98e-05	0.000781	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.96e-05	0.000777	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—adrenal gland cancer	2.87e-05	0.000752	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNRH1—adrenal gland cancer	2.85e-05	0.000748	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTGS2—adrenal gland cancer	2.81e-05	0.000736	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN2A—adrenal gland cancer	2.73e-05	0.000716	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MEN1—adrenal gland cancer	2.73e-05	0.000716	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.67e-05	0.000702	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CDC42—adrenal gland cancer	2.62e-05	0.000687	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SPRY2—adrenal gland cancer	2.61e-05	0.000684	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TSHR—adrenal gland cancer	2.54e-05	0.000667	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GNAS—adrenal gland cancer	2.5e-05	0.000657	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MEN1—adrenal gland cancer	2.39e-05	0.000627	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MED12—adrenal gland cancer	2.39e-05	0.000627	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PRKACA—adrenal gland cancer	2.22e-05	0.000584	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PRKACA—adrenal gland cancer	2.18e-05	0.000573	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—adrenal gland cancer	2.17e-05	0.00057	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.14e-05	0.000561	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.13e-05	0.00056	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRKACA—adrenal gland cancer	2.08e-05	0.000546	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKACA—adrenal gland cancer	1.82e-05	0.000479	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNAS—adrenal gland cancer	1.8e-05	0.000473	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ABCB1—adrenal gland cancer	1.77e-05	0.000464	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNAS—adrenal gland cancer	1.77e-05	0.000464	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDC42—adrenal gland cancer	1.77e-05	0.000463	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PRKACA—adrenal gland cancer	1.74e-05	0.000457	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCB1—adrenal gland cancer	1.74e-05	0.000455	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.7e-05	0.000447	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—POMC—adrenal gland cancer	1.69e-05	0.000442	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDC42—adrenal gland cancer	1.55e-05	0.000406	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—adrenal gland cancer	1.52e-05	0.000399	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF2—adrenal gland cancer	1.49e-05	0.000391	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNAS—adrenal gland cancer	1.48e-05	0.000388	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1R—adrenal gland cancer	1.44e-05	0.000378	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TERT—adrenal gland cancer	1.42e-05	0.000372	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNAS—adrenal gland cancer	1.41e-05	0.000371	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—adrenal gland cancer	1.39e-05	0.000366	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCB1—adrenal gland cancer	1.39e-05	0.000364	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TERT—adrenal gland cancer	1.24e-05	0.000326	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BAD—adrenal gland cancer	1.23e-05	0.000323	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—POMC—adrenal gland cancer	1.21e-05	0.000319	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—POMC—adrenal gland cancer	1.19e-05	0.000312	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BRAF—adrenal gland cancer	1.12e-05	0.000294	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BAD—adrenal gland cancer	1.08e-05	0.000283	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—POMC—adrenal gland cancer	9.96e-06	0.000261	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BRAF—adrenal gland cancer	9.83e-06	0.000258	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—adrenal gland cancer	9.68e-06	0.000254	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—adrenal gland cancer	9.53e-06	0.00025	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—POMC—adrenal gland cancer	9.51e-06	0.00025	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—adrenal gland cancer	9.5e-06	0.000249	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—adrenal gland cancer	9.06e-06	0.000238	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CTNNB1—adrenal gland cancer	8.11e-06	0.000213	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—adrenal gland cancer	7.59e-06	0.000199	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.1e-06	0.000186	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—adrenal gland cancer	6.42e-06	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—adrenal gland cancer	5.63e-06	0.000148	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—adrenal gland cancer	4.73e-06	0.000124	CbGpPWpGaD
